Population-Wide Screening for Chronic Kidney Disease

医学 肾脏疾病 人口 队列 质量调整寿命年 成本效益 透析 全国健康与营养检查调查 重症监护医学 医疗补助 内科学 儿科 医疗保健 环境卫生 经济 风险分析(工程) 经济增长
作者
Marika Cusick,Rebecca L. Tisdale,Glenn M. Chertow,Douglas K Owens,Jeremy D. Goldhaber‐Fiebert
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:176 (6): 788-797 被引量:48
标识
DOI:10.7326/m22-3228
摘要

Background: Sodium–glucose cotransporter-2 (SGLT2) inhibitors have the potential to alter the natural history of chronic kidney disease (CKD), and they should be included in cost-effectiveness analyses of screening for CKD. Objective: To determine the cost-effectiveness of adding population-wide screening for CKD. Design: Markov cohort model. Data Sources: NHANES (National Health and Nutrition Examination Survey), U.S. Centers for Medicare & Medicaid Services data, cohort studies, and randomized clinical trials, including the DAPA-CKD (Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease) trial. Target Population: Adults. Time Horizon: Lifetime. Perspective: Health care sector. Intervention: Screening for albuminuria with and without adding SGLT2 inhibitors to the current standard of care for CKD. Outcome Measures: Costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs), all discounted at 3% annually. Results of Base-Case Analysis: One-time CKD screening at age 55 years had an ICER of $86 300 per QALY gained by increasing costs from $249 800 to $259 000 and increasing QALYs from 12.61 to 12.72; this was accompanied by a decrease in the incidence of kidney failure requiring dialysis or kidney transplant of 0.29 percentage points and an increase in life expectancy from 17.29 to 17.45 years. Other options were also cost-effective. During ages 35 to 75 years, screening once prevented dialysis or transplant in 398 000 people and screening every 10 years until age 75 years cost less than $100 000 per QALY gained. Results of Sensitivity Analysis: When SGLT2 inhibitors were 30% less effective, screening every 10 years during ages 35 to 75 years cost between $145 400 and $182 600 per QALY gained, and price reductions would be required for screening to be cost-effective. Limitation: The efficacy of SGLT2 inhibitors was derived from a single randomized controlled trial. Conclusion: Screening adults for albuminuria to identify CKD could be cost-effective in the United States. Primary Funding Source: Agency for Healthcare Research and Quality, Veterans Affairs Office of Academic Affiliations, and National Institute of Diabetes and Digestive and Kidney Diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
2秒前
4秒前
Xiaoyang完成签到,获得积分10
4秒前
loski发布了新的文献求助10
4秒前
5秒前
虚心月饼发布了新的文献求助10
6秒前
7秒前
Lucas应助123采纳,获得10
9秒前
香蕉觅云应助KIORking采纳,获得10
10秒前
10秒前
Liufgui应助执着又蓝采纳,获得20
11秒前
11秒前
正直水池完成签到 ,获得积分10
11秒前
11秒前
阿克完成签到,获得积分10
11秒前
一方通行发布了新的文献求助10
12秒前
perovskite完成签到,获得积分10
12秒前
如梦如幻91完成签到,获得积分10
12秒前
12秒前
12秒前
妮露的修狗完成签到,获得积分10
13秒前
14秒前
15秒前
文献发布了新的文献求助30
17秒前
无花果应助我不吃胡萝卜采纳,获得10
18秒前
18秒前
19秒前
自信的电灯胆完成签到,获得积分20
19秒前
量子星尘发布了新的文献求助10
20秒前
21秒前
22秒前
清辉夜凝发布了新的文献求助10
22秒前
24秒前
少敏敏发布了新的文献求助10
25秒前
26秒前
嘻哈发布了新的文献求助10
28秒前
苏y发布了新的文献求助10
28秒前
凶狠的乐巧完成签到,获得积分10
29秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989378
求助须知:如何正确求助?哪些是违规求助? 3531442
关于积分的说明 11254002
捐赠科研通 3270126
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173